Financial Snapshot
What does Nasdaq’s latest financial snapshot show?
Strong. The biggest strength is recurring revenue and a high margin profile, while the main concern is post-Adenza debt and deleveraging execution. For context, Exploring Nasdaq, Inc. (NDAQ) Investor Profile: Who's Buying and Why? adds useful ownership context.
The latest verified fiscal period is 2025, with adjusted operating margin updated as of April 13, 2026. This verdict combines growth, profitability, cash generation, balance-sheet capacity, and capital efficiency, so it reflects both the stronger software mix and the leverage investors still need to watch.
Free cash flow deserves deeper analysis first because it shows whether Nasdaq’s earnings quality and debt reduction can support the current margin profile.
Revenue Quality
How durable is Nasdaq, Inc.’s revenue and earnings growth?
Strong. Nasdaq, Inc.’s earnings grew faster than revenue in the supplied full-year data, which points to operating leverage, while $31B of ARR and completed cross-sell deals give the clearest support for durability.
Growth quality matters here because Nasdaq, Inc. is not just trying to grow revenue; it also needs that growth to hold up in operating income, net income, and EPS across comparable annual periods. The stronger the recurring mix and cross-sell momentum, the less the business depends on volatile transaction activity.
| Measure | Latest Period | Previous Period | Quality Test | Investor Meaning |
|---|---|---|---|---|
| Revenue | $525B, up 1291% year-over-year, fiscal 2025 | Fiscal 2024 revenue was not supplied | Unclear mix; supported by solutions-led durability, recurring ARR, and less reliance on transaction volatility | The growth looks more repeatable if recurring solutions keep expanding |
| Operating Income | Not supplied for fiscal 2025 | Not supplied for fiscal 2024 | Unable to verify the operating income bridge from the provided annual data | Investors cannot fully test operating leverage from the annual figures alone |
| Net Income | $179B, up 6007%, fiscal 2025 | Fiscal 2024 net income was not supplied | Final earnings improved sharply, and the result supports stronger earnings quality | The bottom line confirms that growth translated into much stronger reported profit |
| Diluted EPS | Not supplied | Not supplied | Share-count impact cannot be verified from the supplied data | Investors cannot tell from EPS whether per-share gains matched business growth |
How durable is Nasdaq, Inc.’s revenue stream?
Fairly durable. The strongest signal is $31B of ARR at year-end 2025, while the biggest limitation is that transaction exposure still exists and the supplied data does not break out the full mix.
- Demand Quality: Recurring ARR, cross-sell execution, and solutions revenue guidance support visibility better than pure transaction activity.
- Pricing and Volume: The split is unavailable in the supplied data, so the quality view rests on ARR and cross-sell rather than a verified price-volume mix.
- Diversification: 42 successful cross-sell deals by year-end 2025 help reduce dependence on any single product path, but concentration details were not supplied.
That mix should help profitability and cash conversion if the recurring base keeps expanding.
Profitability and Cash
Are Nasdaq, Inc. profits turning into cash?
Nasdaq, Inc.’s operating profitability improved, with an approximately 54% adjusted operating margin and Q2 2025 Operating Income of $568M, up from $423M. But operating cash flow, capital spending, and free cash flow were not supplied here, so cash conversion cannot be confirmed yet.
Gross margin and net margin are not supplied in the provided data, so this section should focus on operating profitability versus cash generation. Nasdaq, Inc. also points to a solutions-led revenue mix, an AI productivity program targeting $100M in run-rate expense efficiency by year-end 2027, and 2026 non-GAAP operating expense guidance of $2455B to $2535B. For mission context, see Mission Statement, Vision, & Core Values (2026) of Nasdaq, Inc. (NDAQ).
| Measure | Latest Period | Previous Period | Verified Driver | Investor Meaning |
|---|---|---|---|---|
| Gross Margin | Not supplied | Not supplied | No verified gross-margin or pricing/mix detail provided | Cannot assess product economics from the supplied data |
| Operating Margin | approximately 54% adjusted operating margin | Not supplied | Solutions-led revenue mix and AI productivity efforts targeting $100M in run-rate expense efficiency by year-end 2027 | Suggests scale and cost discipline are supporting operating efficiency |
| Net Margin | Not supplied | Not supplied | No verified interest, tax, or unusual-item detail provided | Final profitability cannot be tied to cash impact from the supplied data |
| Operating Cash Flow | Not supplied | Not supplied | Cash Flow Statement values and working-capital effects were not supplied | Cannot confirm whether reported earnings converted into operating cash |
| Free Cash Flow | Not supplied | Not supplied | Capex was not supplied; free cash flow means operating cash flow minus capital spending | Cannot judge reinvestment capacity or financing flexibility |
What most affects Nasdaq, Inc.’s cash conversion?
The biggest verified driver is operating leverage from a solutions-led mix and AI-led cost efficiency, but cash conversion still cannot be tested without operating cash flow and capital spending data.
- Main Driver: Solutions-led growth and expense efficiency appear structural, but the cash effect is still unverified.
- Evidence Gap: No operating cash flow, working-capital, or capex figures were supplied.
- Metric to Monitor: Next to track: operating cash flow and free cash flow.
Balance Sheet Strength
Can Nasdaq, Inc. fund itself and manage debt?
Balance sheet: Strong. Nasdaq, Inc. has an asset base that exceeds liabilities, and it has handled its 2025 debt maturities while keeping an investment-grade credit profile. The main protection is scale and access to financing; the main concern is the still-material debt load tied to the Adenza acquisition.
Cash alone does not answer the question. A useful balance-sheet read also has to consider working capital, asset quality, debt service, solvency, liquidity, and refinancing capacity together, because a company can look stable on paper but still face pressure if obligations or asset values shift.
| Area | Latest Evidence | Assessment | Investor Meaning |
|---|---|---|---|
| Cash and Working Capital | Q2 2025 Total Assets of $3038B and Total Liabilities of $1857B; latest supplied liquidity detail does not include current assets, current liabilities, or cash balances. | Strong | Near-term obligations appear supported by the asset base, but the missing current-ratio detail means short-term flexibility still needs monitoring. |
| Total and Net Debt | Total liabilities remain material after the 2023 Adenza transaction; the company is targeting a leverage ratio of 33x within 36 months of the Adenza acquisition close. | Mixed | Leverage is manageable, but it still limits flexibility more than a lightly levered balance sheet would. |
| Debt Service and Refinancing | Nasdaq, Inc. successfully managed its 2025 debt maturities while maintaining an investment-grade credit profile; no later debt schedule or interest detail was supplied. | Strong | That supports refinancing access and suggests it can cover debt service without immediate stress. |
| Asset Quality | The Adenza deal likely increased goodwill and intangible assets, so asset quality depends on how much of the balance sheet sits in acquired intangibles; no amounts were supplied. | Mixed | Goodwill and intangibles can support scale, but they also raise impairment risk if performance weakens. |
| Liabilities and Equity | Total liabilities were $1857B; latest verified shareholders' equity was not supplied. | Strong | Liabilities are large, but the asset base still covers them, which helps absorb shocks. |
What balance-sheet risk matters most for Nasdaq, Inc.?
The biggest monitorable risk is refinancing and leverage tied to Adenza. Nasdaq, Inc. has already handled 2025 maturities, but the remaining debt load and any pressure on goodwill or intangibles deserve the closest watch.
- Current Exposure: Q2 2025 total assets of $3038B versus total liabilities of $1857B.
- Protection: Investment-grade credit profile and successful management of 2025 debt maturities.
- Warning Signal: Watch the deleveraging path toward a 33x leverage ratio and any slowdown in refinancing access.
If you’re using this topic for a paper or case study, a structured SWOT Analysis, PESTLE Analysis, or Business Model Canvas can help you organize the research into clear arguments. For deeper company research, see the Mission Statement, Vision, & Core Values (2026) of Nasdaq, Inc. (NDAQ).
Capital Efficiency
Is Nasdaq, Inc. earning adequate returns while funding growth?
Nasdaq, Inc. looks Mixed. Internal cash appears useful for reinvestment, but the prompt does not provide verified ROIC, ROE, ROA, capex, or cash conversion, so the return profile cannot be rated as clearly strong.
Return analysis for Nasdaq, Inc. has to be read alongside leverage, asset intensity, capital expenditure, working capital, and any outside funding needs. Nasdaq, Inc. also uses share repurchases to manage dilution from employee equity vesting, which affects equity count more than it proves underlying operating efficiency. For background on the company’s direction, see Mission Statement, Vision, & Core Values (2026) of Nasdaq, Inc. (NDAQ).
| Capital Measure | Latest Evidence | Quality Test | Investor Meaning |
|---|---|---|---|
| ROIC | Unavailable in the supplied data. | Nasdaq, Inc. needs operating margin and capital efficiency evidence before ROIC can be judged. | Without verified ROIC, it is not possible to tell whether invested capital is creating operating value. |
| ROE and ROA | Unavailable in the supplied data. | ROE would reflect leverage, while ROA would reflect asset intensity, but neither can be tested here. | Shareholder return quality and asset efficiency remain unverified. |
| Maintenance and Growth Investment | R&D investment of $650M for the 2024 fiscal year, with increased allocations for AI and predictive intelligence in 2025; AI-enabled innovation across Verafin, eVestment, AxiomSL, and Calypso; cloud partnership with AWS to improve resiliency and scalability; Private Capital Indexes based on data from over 14000 funds with $114T in assets under management; ETP AUM of $882B in the Index business at December 31, 2025; Adenza integration; 42 successful cross-sell deals completed by year-end 2025; $100M cross-sell run-rate revenue target by year-end 2027 | The evidence supports ongoing growth investment, but the prompt does not separate maintenance spending from expansion spending. | Capital appears aimed at recurring revenue, cross-sell, integration, and operating efficiency rather than near-term valuation. |
| Internal Funding Capacity | Internal cash, debt, and equity are mentioned, but only share repurchases are verified here as dilution management. | Funding appears partly internally supported, but the prompt does not verify full cash flow or debt capacity. | Nasdaq, Inc. may fund reinvestment internally, but the absence of cash flow data limits confidence about flexibility and shareholder returns. |
Are Nasdaq, Inc. returns on capital sustainable?
Probably, but only if AI-driven product upgrades, AWS-enabled scalability, and Adenza cross-sell keep lifting recurring revenue. Returns would weaken if reinvestment keeps rising faster than operating cash generation or if integration costs stay elevated.
- Operating Source: AI-enabled innovation, recurring revenue, and cross-sell momentum across Verafin, eVestment, AxiomSL, and Calypso.
- Funding Requirement: The largest verified need is ongoing R&D and integration spending tied to AI, predictive intelligence, and Adenza.
- Durability Test: Watch whether operating cash flow and cross-sell run-rate progress keep pace with reinvestment and dilution management.
Balance Sheet Risk
How resilient is Nasdaq, Inc. financially, and which warning signs matter most?
Mixed. Nasdaq, Inc.’s main buffer is its diversified revenue mix, including index licensing and anti-financial crime software. The most important verified warning sign is post-Adenza leverage and refinancing exposure if deleveraging stalls.
Nasdaq, Inc. can still support liquidity and core investment because it is not relying only on trading activity, but it is less resilient if fees, leverage, or integration costs rise at the same time. Regulatory pressure, debt reduction progress, and execution on synergy targets will matter most for financial flexibility.
| Pressure | Financial Effect | Existing Protection | Warning Signal |
|---|---|---|---|
| Revenue or Margin Pressure | Market data fee pressure and SEC best-execution rules could squeeze legacy margins, reduce operating leverage, and limit cash flow available for debt reduction. | Diversification into non-trading revenues such as index licensing and anti-financial crime software can cushion the mix. | Watch for declining adjusted operating margin or weaker cash flow from the core market services base. |
| Working-Capital or Investment Pressure | Integration, cybersecurity, and operational resilience spending can absorb cash and slow the pace of deleveraging if costs run above plan. | Internal funding capacity and regulatory alignment actions, including the June 02, 2026 Global Data Agreement restructuring and Appendix 3 update, can help limit friction. | Monitor operating cash flow, rising operating expense, or slower progress on ARR and cross-sell targets. |
| Interest or Refinancing Pressure | Post-Adenza leverage can constrain flexibility, raise refinancing sensitivity, and reduce room for error if maturities or rates worsen. | Nasdaq, Inc. has an investment-grade credit profile and management has a 33x leverage target within 36 months of the Adenza acquisition close. | Watch the leverage ratio, 2025 debt maturities, and any sign that refinancing terms become less favorable. |
Which financial warning signs should investors monitor at Nasdaq, Inc.?
The top signals are leverage progress, adjusted operating margin, and operating cash flow. Confirmed deterioration would show up in stalled deleveraging or margin pressure; future risk is slower ARR and cross-sell progress against the $100M run-rate revenue target by year-end 2027.
Leverage Stalls After Adenza
If the leverage ratio stops moving toward the 33x target, refinancing flexibility could tighten. The investment-grade profile helps, but the next metric is debt reduction versus 2025 maturities and cash generation.
Margin Pressure From Regulation
SEC scrutiny of market data fees and best-execution rules could weigh on legacy margins. Diversified revenues help, so the key metric is adjusted operating margin, especially if fee pressure starts to hit cash flow.
Integration Costs Outrun Synergies
Execution risk matters if cybersecurity, operations, or cross-sell spending rises faster than expected benefits. Watch ARR and the $100M cross-sell run-rate revenue target by year-end 2027 for evidence of progress.
Financial Health Scorecard
How should investors read Nasdaq, Inc. financial health scorecard?
Overall rating: Mixed. The strongest factor is $31B ARR with cross-sell momentum and high adjusted margins. The weakest factor is the debt and leverage path after Adenza. The most important condition is whether recurring growth stays strong while deleveraging continues.
| Financial Factor | Rating | Evidence and Investor Meaning |
|---|---|---|
| Revenue and Earnings Quality | Strong | $525B Annual Revenue 2025 and $179B Annual Net Income 2025 show sharp growth, while $31B ARR and cross-sell progress support recurring, higher-quality earnings. |
| Profitability and Cash | Mixed | About 54% adjusted operating margin is strong, but operating cash flow, capex, and free cash flow are not supplied here, so cash strength cannot be fully tested. |
| Balance Sheet and Liquidity | Mixed | Q2 2025 Total Assets of $3038B exceeded Total Liabilities of $1857B, and investment-grade status was maintained, but leverage still matters after Adenza. |
| Capital Efficiency | Mixed | AI, R&D, cloud, and Adenza integration support reinvestment, but verified ROIC, ROE, ROA, and cash-return metrics are not supplied here, limiting efficiency judgment. |
| Financial Resilience | Strong | Recurring revenue, non-trading revenue diversification, regulatory compliance actions, and operational modernization provide buffers against market stress and execution risk. |
- What Supports the Thesis: $31B ARR, recurring solutions revenue, and about 54% adjusted operating margin create a durable earnings base.
- What Challenges the Thesis: Debt and leverage after Adenza remain the main uncertainty, especially if deleveraging slows or reinvestment weakens.
- What to Monitor: ARR, adjusted operating margin, leverage ratio.
For deeper context on strategy and operating priorities, see Mission Statement, Vision, & Core Values (2026) of Nasdaq, Inc. (NDAQ); those factors shape the forecasts, scenarios, and valuation assumptions behind this scorecard.
FAQ
What Do Investors Ask About 's Financial Health?
Investors most often ask about the company's revenue quality, profitability, cash generation, debt, liquidity, capital efficiency, and ability to withstand financial pressure.
How much debt remains after Adenza integration?
The supplied data does not provide a current debt balance Investors should focus on the deleveraging plan targeting a leverage ratio of 33x within 36 months of the Adenza acquisition close and the company’s investment-grade profile
Is Nasdaq liquidity enough to support dividends?
The supplied data confirms a $027 per share cash dividend and a 125% year-over-year increase, but it does not provide dividend coverage Investors should compare future cash flow, capex, debt service, and payout ratio progress
Does recurring revenue improve Nasdaq cash stability?
Yes, recurring revenue can improve visibility because Nasdaq reported $31B in ARR at year-end 2025 Still, investors should verify cash conversion through operating cash flow and free cash flow when those figures are available
What weakens Nasdaq financial resilience most?
The main financial resilience risks are leverage after Adenza, regulatory pressure on market data fees, and execution risk around cross-sell and integration These could affect margins, liquidity flexibility, and the pace of deleveraging
Are Nasdaq returns on capital clearly strong?
The supplied data does not include verified ROIC, ROE, or ROA Investors can view reinvestment activity positively, including AI, R&D, and Adenza cross-sell progress, but should not label capital returns strong without those metrics